National Cancer Center Japan Joins Caris' Precision Oncology

IRVING, Texas, Feb. 10, 2022 /PRNewswire/ -- Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, announced today that the

Related Keywords

New York , United States , Phoenix , Arizona , Japan , Tokyo , Switzerland , Texas , Denver , Colorado , Japanese , Chadi Nabhan , Takayuki Yoshino , Allison Kreutzjans , National Cancer Center Hospital , Caris , Head Of Clinical Research Coordination Division , National Cancer Center Japan , Caris Life Sciences Media Contact , Prnewswire Caris Life Sciences , Precision Oncology Alliance , Japan Ministry Of Health , National Cancer Center , Cari Precision Oncology Alliance , Caris Life Sciences , Caris Precision Oncology Alliance , Life Sciences , Clinical Research Coordination Division , Gastrointestinal Oncology , Caris Precision Oncology , Whole Exome , Whole Transcriptome Sequencing , Life Sciences Media Contact , Tncen , West Southwest , United States Of America , North America , Sia ,